rss
Arch Dis Child Fetal Neonatal Ed 2001;85:F145 doi:10.1136/fn.85.2.F145g
  • Letters to the editor

Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?

  1. GEOFFREY K ISBISTER,
  2. ANDREW DAWSON,
  3. IAN M WHYTE
  1. Department of Clinical Toxicology and Pharmacology
  2. Newcastle Mater Hospital
  3. Newcastle, Australia
  4. gsbite@bigpond.com
  5. Hunter Drug Information Service
  6. Newcastle, Australia
  7. Discipline of Clinical Pharmacology
  8. University of Newcastle, Australia
    1. FELICITY H PRIOR,
    2. CHRISTINE CLANCY
    1. Department of Clinical Toxicology and Pharmacology
    2. Newcastle Mater Hospital
    3. Newcastle, Australia
    4. gsbite@bigpond.com
    5. Hunter Drug Information Service
    6. Newcastle, Australia
    7. Discipline of Clinical Pharmacology
    8. University of Newcastle, Australia
      1. ANTHONY J SMITH
      1. Department of Clinical Toxicology and Pharmacology
      2. Newcastle Mater Hospital
      3. Newcastle, Australia
      4. gsbite@bigpond.com
      5. Hunter Drug Information Service
      6. Newcastle, Australia
      7. Discipline of Clinical Pharmacology
      8. University of Newcastle, Australia

          Editor—We would like to comment on the article “Neonatal paroxetine withdrawal syndrome” in the March 2001 issue of the journal.1 The authors describe what they have called “neonatal paroxetine withdrawal syndrome”. However the syndrome reported in the 4 neonates appears to be more consistent with serotonin toxicity, rather than withdrawal of paroxetine.

          The literature to date contains one large series,2 two similar case reports with fluoxetine3 4 and two case reports with paroxetine.5 6

          In the fluoxetine cases the syndrome was not described as a withdrawal phenomenon. In the first, a neonate born to a mother on fluoxetine had jitteriness, irritability, tachypnoea, temperature instability, tremors, increased muscle tone, and a hyperactive Moro reflex.3 All except the last of these are clinical features seen in serotonin toxicity in adults using selective serotonin uptake inhibitors (SSRIs) therapeutically or in overdose.7 8 The neonate in this case had fluoxetine …

          Latest from Education & Practice

          Latest from Education & Practice

          Register for free content

          Free sample
          This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ADC Fetal & Neonatal.
          View free sample issue >>

          Free archive
          The full back archive is now available for ADC Fetal & Neonatal. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
          Register to access the free archive >>

          Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

        • Paediatrics and Paediatric Surgery Jobs

          Paediatrics and Paediatric Surgery Jobs